Sign in
4

Changes in Ownership

Aclaris Therapeutics, Inc. Filed Acc 0001209191-22-001712

Chief Legal Officer acquired 45,518 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Ali-Jackson Kamil · Chief Legal Officer

Table I: Non-derivative

4 lines
Date Transaction Shares Owned after D/I
2022-01-03 Exercise or conversion : show line 1 in the form +3,875 118,571 D
2022-01-03 Exercise or conversion : show line 2 in the form +27,905 146,476 D
2022-01-03 Exercise or conversion : show line 3 in the form +6,638 153,114 D
2022-01-03 Exercise or conversion : show line 4 in the form +7,100 160,214 D

Table II: Derivative

4 lines
Date Transaction Shares Owned after D/I
2022-01-03 Exercise or conversion : show line 5 in the form Restricted Stock Units −3,875 0 D
2022-01-03 Exercise or conversion : show line 6 in the form Restricted Stock Units −27,905 0 D
2022-01-03 Exercise or conversion : show line 7 in the form Restricted Stock Unit −6,638 0 D
2022-01-03 Exercise or conversion : show line 8 in the form Restricted Stock Units −7,100 0 D
Loading xslF345X03/doc4.xml…